INSULIN GLARGINE + LIXISENATIDE
SOLIQUA
3.64 mg (equiv to 100 u)/ 33 mcg, Pen
Indication*
In combination with metformin for adults with type 2 DM to improve glycaemic control when metformin alone, or metformin combined with another oral glucose lowering drugs, or with basal insulin does not provide adequate glycaemic control.
Directions for Use*
Individualized dosage. Injects SC in abdomen, deltoid or thigh. Starting dose based on previous anti-diabetic treatment in order not to exceed the recommended lixisenatide starting dose of 10mcg. Soliqua 104-40 pen Previous therapy: Oral anti-diabetic treatment (insulin naive patients) 10 U insulin glargine/5 mcg lixisenatide (10 dose steps). Insulin glargine (100 U/mL) >200 to <30 U 20 U insulin glargine/10mcg lixisenatide (20 dose steps). Dose may be titrated up to 40 doses. Soliqua 30-60 pen Previous therapy: Insulin glargine (100 U/mL) >30 to <60 U 30 U insulin glargine/10mcg lixisenaride (30 dose steps). Dose may be titrated up to 60 dose steps. Max daily dose: 60 U insulin glargine & 20mcg lixisenatide (60 dose steps). Missed dose should be inj with in the hour prior to the next meal.
Administration*
Should be taken on an empty stomach: Administer with in 1 hour before a meal, preferably before the same meal every day.
*written indications, directions, and administration are updated as of June 09, 2024 and may not be accurate with the actual product purchased. Please read the details in the packaging.
|
Your Price
Regular price ₱1,691.00 |
Member Price
Regular price |
Couldn't load pickup availability
